Open Cannabis Project Dissolves in Response to Controversy Over Ag-Science Company Phylos Bioscience’s Breeding Program

Spread the love

Adobe Stock Open Cannabis Project Dissolves in Response to Controversy Over Ag-Science Company Phylos Bioscience’s Breeding Program The Oregon nonprofit that aimed to protect the cannabis genome from patent trolls dissolved May 6 in response to intense backlash against its former business partner Phylos Bioscience.

Subscribe May 7, 2019
Willamette Week Grower/Agriculture News State by State: Oregon

The Open Cannabis Project, an Oregon nonprofit that aimed to protect the cannabis genome from patent trolls, dissolved May 6, in response to intense backlash against its former business partner Phylos Bioscience.

The nonprofit spun off from Phylos in November 2017, but its executive director Beth Schechter says people’s suspicions about Phylos, an ag-science company, continued to pop up in messages from the community.

Last month, Phylos Bioscience announced its intent to launch a breeding program to create new, better strains of cannabis and hemp. Many farmers in the industry balked at the news because they had given the company genomic data with the understanding that it would not be used to enhance a breeding program.

Read more

Cultivars Cannabis Cultivator Cannabis Grower Oregon Breeding Geocann Launches CBD Soft Gel Formulations Utilizing Patented Drug Delivery Technology The condition-specific portfolio showcases clinically measured bioavailability and science-backed cannabinoid and terpene ratios.

Subscribe May 7, 2019
Posted by Melissa Schiller Medical News

FORT COLLINS, Colo., May 06, 2019 (GLOBE NEWSWIRE) — PRESS RELEASE — Geocann has announced that the company has successfully commercialized the first formulation in a robust portfolio of CBD soft gel products that utilize the multi-patented VESIsorb delivery system for optimal absorption and measured bioavailability. The formulation is loaded with a science-backed two-to-one ratio of CBD to BCP (beta-caryophyllene) which has been shown to have a synergistic effect as agonists for the CB2, 5-HT1A and glycine receptors.

View the Original article

error: Content is protected !!
%d blogueurs aiment cette page :